Alcon (ALC) Stock Forecast, Price Target & Predictions
ALC Stock Forecast
Alcon stock forecast is as follows: an average price target of $93.89 (represents a 9.42% upside from ALC’s last price of $85.81) and a rating consensus of 'Buy', based on 14 wall street analysts offering a 1-year stock forecast.
ALC Price Target
ALC Analyst Ratings
Buy
Alcon Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Oct 15, 2024 | Brett Fishbin | KeyBanc | $107.00 | $97.59 | 9.64% | 24.69% |
Aug 22, 2024 | Larry Biegelsen | Wells Fargo | $105.00 | $95.56 | 9.88% | 22.36% |
Aug 22, 2024 | Steven Lichtman | Oppenheimer | $110.00 | $95.56 | 15.11% | 28.19% |
Aug 22, 2024 | Jeff Johnson | Robert W. Baird | $110.00 | $95.56 | 15.11% | 28.19% |
Aug 22, 2024 | David Saxon | Needham | $107.00 | $95.56 | 11.97% | 24.69% |
Jul 15, 2024 | Patrick Wood | Morgan Stanley | $85.00 | $89.96 | -5.51% | -0.94% |
May 16, 2024 | Anthony Petrone | Mizuho Securities | $105.00 | $89.97 | 16.71% | 22.36% |
May 15, 2024 | Steve Lichtman | Oppenheimer | $103.00 | $89.28 | 15.37% | 20.03% |
May 15, 2024 | Jeff Johnson | Robert W. Baird | $104.00 | $89.28 | 16.49% | 21.20% |
May 15, 2024 | Larry Biegelsen | Wells Fargo | $94.00 | $89.28 | 5.29% | 9.54% |
10
Alcon Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 5 | 17 |
Avg Price Target | - | $107.80 | $100.00 |
Last Closing Price | $85.81 | $85.81 | $85.81 |
Upside/Downside | -100.00% | 25.63% | 16.54% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 15, 2024 | KeyBanc | Overweight | Overweight | Hold |
Sep 12, 2024 | BTIG | Buy | Buy | Hold |
Sep 10, 2024 | RBC Capital | - | Outperform | Upgrade |
Aug 22, 2024 | Needham | Buy | Buy | Hold |
Aug 22, 2024 | Oppenheimer | Outperform | Outperform | Hold |
Aug 22, 2024 | Wells Fargo | Overweight | Overweight | Hold |
Aug 22, 2024 | BTIG | Buy | Buy | Hold |
Jul 15, 2024 | BTIG | Buy | Buy | Hold |
May 15, 2024 | Oppenheimer | - | Outperform | Upgrade |
May 15, 2024 | Wells Fargo | Overweight | Overweight | Hold |
10
Alcon Financial Forecast
Alcon Revenue Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.35B | $2.17B | $2.14B | $2.22B | $2.19B | $2.15B | $2.10B | $2.11B | $1.93B | $1.94B | $1.84B | $1.21B | $1.84B | $1.91B | $1.87B |
Avg Forecast | $2.83B | $2.76B | $2.83B | $2.75B | $2.63B | $2.57B | $2.61B | $2.54B | $2.44B | $2.51B | $2.50B | $2.46B | $2.42B | $2.29B | $2.33B | $2.22B | $2.19B | $2.09B | $2.25B | $2.12B | $2.11B | $2.01B | $1.92B | $1.89B | $1.93B | $1.67B | $1.21B | $1.72B | $1.91B | $1.81B |
High Forecast | $2.86B | $2.79B | $2.86B | $2.78B | $2.66B | $2.60B | $2.64B | $2.55B | $2.47B | $2.53B | $2.53B | $2.48B | $2.50B | $2.38B | $2.35B | $2.25B | $2.21B | $2.09B | $2.25B | $2.12B | $2.11B | $2.01B | $1.92B | $1.89B | $1.93B | $1.67B | $1.21B | $1.72B | $1.91B | $1.81B |
Low Forecast | $2.81B | $2.74B | $2.80B | $2.73B | $2.61B | $2.55B | $2.59B | $2.53B | $2.42B | $2.48B | $2.48B | $2.44B | $2.39B | $2.19B | $2.31B | $2.20B | $2.17B | $2.09B | $2.25B | $2.12B | $2.11B | $2.01B | $1.92B | $1.89B | $1.93B | $1.67B | $1.21B | $1.72B | $1.91B | $1.81B |
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 6 | 3 | 7 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 | 4 | 4 | 4 | 6 | 4 | 4 | 7 | 4 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.06% | 0.99% | 1.02% | 0.98% | 1.03% | 1.02% | 1.05% | 1.10% | 1.02% | 1.00% | 1.10% | 1.01% | 1.07% | 1.00% | 1.03% |
Forecast
Alcon EBITDA Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 6 | 3 | 7 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 | 4 | 4 | 4 | 6 | 4 | 4 | 7 | 4 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $260.00M | $9.00M | $444.00M | $499.00M | $492.00M | $427.00M | $439.00M | $467.00M | $424.00M | $552.00M | $291.00M | $-65.00M | $337.00M | $274.00M | $355.00M |
Avg Forecast | $556.58M | $543.51M | $556.00M | $540.98M | $517.23M | $505.62M | $513.94M | $500.48M | $479.51M | $492.76M | $491.68M | $412.14M | $475.98M | $449.90M | $457.31M | $374.68M | $402.60M | $419.01M | $451.73M | $340.62M | $423.27M | $402.88M | $386.01M | $386.31M | $387.70M | $335.48M | $242.31M | $227.97M | $384.23M | $363.85M |
High Forecast | $562.39M | $549.18M | $561.79M | $546.62M | $522.62M | $510.89M | $519.30M | $502.42M | $485.33M | $497.89M | $496.80M | $494.57M | $492.26M | $469.03M | $462.08M | $449.61M | $483.12M | $419.01M | $451.73M | $408.74M | $423.27M | $402.88M | $386.01M | $463.57M | $387.70M | $335.48M | $242.31M | $273.56M | $384.23M | $363.85M |
Low Forecast | $551.84M | $538.88M | $551.26M | $536.36M | $512.82M | $501.31M | $509.56M | $498.54M | $475.62M | $488.55M | $487.48M | $329.72M | $469.88M | $430.77M | $453.41M | $299.74M | $322.08M | $419.01M | $451.73M | $272.49M | $423.27M | $402.88M | $386.01M | $309.05M | $387.70M | $335.48M | $242.31M | $182.38M | $384.23M | $363.85M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.69% | 0.02% | 1.06% | 1.10% | 1.44% | 1.01% | 1.09% | 1.21% | 1.10% | 1.42% | 0.87% | -0.27% | 1.48% | 0.71% | 0.98% |
Forecast
Alcon Net Income Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 6 | 3 | 7 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 | 4 | 4 | 4 | 6 | 4 | 4 | 7 | 4 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $174.00M | $-97.00M | $116.00M | $148.00M | $168.00M | $139.00M | $2.00M | $151.00M | $84.00M | $95.00M | $-147.00M | $-422.00M | $-57.00M | $-91.00M | $-66.00M |
Avg Forecast | $458.50M | $458.50M | $473.29M | $483.15M | $418.06M | $408.14M | $405.80M | $408.29M | $355.42M | $374.87M | $358.77M | $140.73M | $348.36M | $320.24M | $315.43M | $127.94M | $131.06M | $237.90M | $286.26M | $116.31M | $247.86M | $246.10M | $223.25M | $76.53M | $205.74M | $110.50M | $-46.72M | $-38.56M | $227.96M | $226.00M |
High Forecast | $464.71M | $464.71M | $479.70M | $489.70M | $423.73M | $413.67M | $411.30M | $418.01M | $379.12M | $379.95M | $366.75M | $168.88M | $358.61M | $323.31M | $319.71M | $153.53M | $157.27M | $237.90M | $286.26M | $139.57M | $247.86M | $246.10M | $223.25M | $91.84M | $205.74M | $110.50M | $-46.72M | $-30.85M | $227.96M | $226.00M |
Low Forecast | $453.42M | $453.42M | $468.04M | $477.80M | $413.43M | $403.61M | $401.30M | $403.43M | $331.73M | $370.72M | $350.80M | $112.59M | $338.11M | $317.17M | $311.94M | $102.35M | $104.85M | $237.90M | $286.26M | $93.05M | $247.86M | $246.10M | $223.25M | $61.23M | $205.74M | $110.50M | $-46.72M | $-46.27M | $227.96M | $226.00M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.36% | -0.74% | 0.49% | 0.52% | 1.44% | 0.56% | 0.01% | 0.68% | 1.10% | 0.46% | -1.33% | 9.03% | 1.48% | -0.40% | -0.29% |
Forecast
Alcon SG&A Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 6 | 3 | 7 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 | 4 | 4 | 4 | 6 | 4 | 4 | 7 | 4 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $785.00M | $762.00M | $762.00M | $803.00M | $741.00M | $813.00M | $779.00M | $785.00M | $699.00M | $737.00M | $685.00M | $595.00M | $677.00M | $714.00M | $717.00M |
Avg Forecast | $1.03B | $1.00B | $1.03B | $998.19M | $954.38M | $932.95M | $948.31M | $923.47M | $884.77M | $909.21M | $907.22M | $620.73M | $878.26M | $830.14M | $843.81M | $564.30M | $766.54M | $766.73M | $826.60M | $513.00M | $774.53M | $737.21M | $706.35M | $636.87M | $709.44M | $613.87M | $443.39M | $457.97M | $703.09M | $665.79M |
High Forecast | $1.04B | $1.01B | $1.04B | $1.01B | $964.33M | $942.68M | $958.19M | $927.05M | $895.51M | $918.69M | $916.68M | $744.88M | $908.29M | $865.44M | $852.61M | $677.16M | $919.85M | $766.73M | $826.60M | $615.60M | $774.53M | $737.21M | $706.35M | $764.24M | $709.44M | $613.87M | $443.39M | $549.56M | $703.09M | $665.79M |
Low Forecast | $1.02B | $994.32M | $1.02B | $989.68M | $946.24M | $925.00M | $940.22M | $919.89M | $877.60M | $901.46M | $899.49M | $496.58M | $867.00M | $794.84M | $836.62M | $451.44M | $613.23M | $766.73M | $826.60M | $410.40M | $774.53M | $737.21M | $706.35M | $509.49M | $709.44M | $613.87M | $443.39M | $366.38M | $703.09M | $665.79M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.39% | 0.99% | 0.99% | 0.97% | 1.44% | 1.05% | 1.06% | 1.11% | 1.10% | 1.04% | 1.12% | 1.34% | 1.48% | 1.02% | 1.08% |
Forecast
Alcon EPS Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 6 | 3 | 7 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 | 4 | 4 | 4 | 6 | 4 | 4 | 7 | 4 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.35 | $-0.20 | $0.24 | $0.30 | $0.34 | $0.28 | - | $0.31 | $0.17 | $0.19 | $-0.30 | $-0.86 | $-0.12 | $-0.19 | $-0.14 |
Avg Forecast | $0.92 | $0.92 | $0.95 | $0.97 | $0.84 | $0.82 | $0.82 | $0.82 | $0.72 | $0.75 | $0.72 | $0.72 | $0.70 | $0.64 | $0.63 | $0.61 | $0.43 | $0.48 | $0.58 | $0.54 | $0.50 | $0.50 | $0.45 | $0.44 | $0.41 | $0.22 | $-0.09 | $0.35 | $0.46 | $0.45 |
High Forecast | $0.94 | $0.94 | $0.97 | $0.99 | $0.85 | $0.83 | $0.83 | $0.84 | $0.76 | $0.76 | $0.74 | $0.73 | $0.72 | $0.65 | $0.64 | $0.62 | $0.43 | $0.48 | $0.58 | $0.54 | $0.50 | $0.50 | $0.45 | $0.44 | $0.41 | $0.22 | $-0.09 | $0.35 | $0.46 | $0.45 |
Low Forecast | $0.91 | $0.91 | $0.94 | $0.96 | $0.83 | $0.81 | $0.81 | $0.81 | $0.67 | $0.75 | $0.71 | $0.72 | $0.68 | $0.64 | $0.63 | $0.60 | $0.42 | $0.48 | $0.58 | $0.54 | $0.50 | $0.50 | $0.45 | $0.44 | $0.41 | $0.22 | $-0.09 | $0.35 | $0.46 | $0.45 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.57% | -0.47% | 0.50% | 0.52% | 0.63% | 0.56% | 0.01% | 0.69% | 0.38% | 0.46% | -1.35% | 9.15% | -0.35% | -0.41% | -0.31% |
Forecast
Alcon Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
COO | Cooper Companies | $99.48 | $298.00 | 199.56% | Buy |
ANGO | AngioDynamics | $6.88 | $15.00 | 118.02% | Buy |
BAX | Baxter | $33.02 | $60.38 | 82.86% | Hold |
TFX | Teleflex | $194.43 | $304.36 | 56.54% | Buy |
BLFS | BioLife Solutions | $20.47 | $27.33 | 33.51% | Buy |
HAE | Haemonetics | $88.17 | $108.25 | 22.77% | Buy |
WST | West Pharmaceutical Services | $307.21 | $345.33 | 12.41% | Buy |
NVST | Envista | $20.61 | $23.11 | 12.13% | Hold |
ALC | Alcon | $85.81 | $93.89 | 9.42% | Buy |
ICUI | ICU Medical | $169.98 | $172.00 | 1.19% | Buy |
MMSI | Merit Medical Systems | $103.94 | $100.78 | -3.04% | Buy |
RMD | ResMed | $239.42 | $219.13 | -8.47% | Hold |
EMBC | Embecta | $14.42 | $12.00 | -16.78% | Sell |
ATR | AptarGroup | $166.69 | $138.00 | -17.21% | Buy |